Stocks in play: Medicenna Therapeutics Corp.
Announced today that Dr. Fahar Merchant, President and CEO of Medicenna, will participate in the ROTH 4th Annual Healthcare Opportunities Conference, taking place at the Metropolitan Club in New York City on October 8-9. Medicenna Therapeutics Corp. shares T.MDNA are trading unchanged at $0.98.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.